中国医药: 关于中国医药健康产业股份有限公司2025年第二次临时股东大会的法律意见书

Group 1 - The legal opinion letter confirms that the procedures for convening and holding the shareholders' meeting comply with the Company Law, Shareholders' Meeting Rules, and the company's articles of association [2][3][4] - The shareholders' meeting was scheduled for May 28, 2025, with a registration date of May 21, 2025, and utilized both on-site and online voting systems [2][3] - A total of 648,953,202 shares, representing 43.3827% of the company's total shares, were represented at the on-site meeting, while 152,601,156 shares, representing 18.0182% of the voting shares, participated in the online voting [3][4] Group 2 - The voting process involved both on-site and online methods, with a total of 151,129,549 shares voting in favor, accounting for 99.0356% of the valid votes cast [5] - The results from minority investors showed that 11,129,549 shares voted in favor, representing 88.3216% of the valid votes from minority shareholders [5] - The legal opinion concludes that the meeting's procedures, participant qualifications, voting methods, and results are all valid and comply with relevant laws and regulations [5][6]